Cargando…
The evaluation of a multi-day testing approach with antigen lateral flow devices for people eligible for community-based COVID-19 treatments
BACKGROUND: COVID-19 therapeutics including antiviral and monoclonal antibody treatments (hereafter ‘COVID-19 treatments’) require rapid administration to be effective. As part of the community-based antiviral and therapeutic treatment pathway for COVID-19 there has been a move from PCR testing in t...
Autores principales: | Fowler, Tom, Fellows, Alasdair, MacISaac, Rachael, Kolade, Olumide, Singh, Bhupinder, Eccles, Adam, Blandford, Edward, Tunkel, Sarah A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10666983/ https://www.ncbi.nlm.nih.gov/pubmed/37995356 http://dx.doi.org/10.1093/jac/dkad313 |
Ejemplares similares
-
Performance of antigen lateral flow devices in the UK during the alpha, delta, and omicron waves of the SARS-CoV-2 pandemic: a diagnostic and observational study
por: Eyre, David W, et al.
Publicado: (2023) -
Duration from seroconversion to eligibility for antiretroviral therapy and from ART eligibility to death in adult HIV-infected patients from low and middle-income countries: collaborative analysis of prospective studies
Publicado: (2008) -
Derivation of parameters used in Spectrum for eligibility for antiretroviral therapy and survival on antiretroviral therapy
por: Mahy, Mary, et al.
Publicado: (2010) -
Financial Support to Eligible Countries for the Switch From Trivalent to Bivalent Oral Polio Vaccine—Lessons Learned
por: Shendale, Stephanie, et al.
Publicado: (2017) -
Abstracts from Rambam Research Day, December 29, 2011
Publicado: (2012)